A neutral ceramidase activity has earlier been identified in the intestinal mucosa and gut lumen and postulated to be important in the digestion of sphingolipids. It is found throughout the intestine, but has never been fully characterized. We now purified rat intestinal neutral ceramidase from an eluate obtained by perfusing the intestinal lumen with 0.9 % NaCl and 3mM sodium taurodeoxycholate. Using a combination of acetone precipitation, ion exchange, hydrophobic interaction and gel chromatographies we obtained a homogenous enzyme protein with a molecular mass around 116 kDa. The enzyme acts on both 14 C-octanoyl-and 14 Cpalmitoyl sphingosine in the presence of glycocholic and taurocholic acid and the bile salt 
Introduction
Sphingolipids occur in dietary meat, milk and fish products and in some vegetable products as soybeans. The daily intake was calculated to be 0.3-0.4 g per day (52) . Suckling babies ingest 80-200 mg milk sphingomyelin (Sm) per day and some glycosphingolipids (36) . The dietary sphingolipids are mixed in the gut with bile Sm and with Sm and glycosphingolipids from sloughed mucosal cells. Sphingolipids in food are sequentially hydrolysed to ceramide, sphingosine and fatty acids (35) but not transported intact via the chyle (34) . In case of Sm the initial step is catalyzed by alkaline sphingomyelinase (Alk-SMase) (35, 39) and in case of glycosyl ceramides by lactase phlorizine hydrolase (21, 23) . The amide bond of the ceramide formed is hydrolysed in the lumen and at the brush border mainly by intestinal ceramidase, the question whether ceramide also permeates intact into mucosal cells being unresolved. Free sphingosine formed is rapidly absorbed, phosphorylated in the mucosal cells to sphingosine-1-phosphate (S-1-P), and converted to chylomicron palmitic acid or incorporated into mucosal ceramide and sphingolipids (34, 47) . Dietary Sm is hydrolyzed mainly in the middle and lower small intestine (35, 39) , where Alk-SMase is most abundant (12) . Digestion of glycosylceramide follows a similar course (33) . Due to the extended course of sphingolipid digestion, the whole small intestine and colon are exposed to the metabolites formed (34, 39) .
Ceramide, sphingosine and S-1-P are signaling substances that influence numerous cell functions, including growth, differentiation and apoptosis (8, 22) . Ceramide and sphingosine commonly favour cell differentiation or growth inhibition and S-1-P has often antagonistic effects (42) . Dietary sphingolipids were shown to counteract chemically induced colon carcinogenesis and tumor development in a chemical carcinogenesis model and in MIN (multiple intestinal neoplasia) mice with an inactivating mutation in the familial adenomatous polyposis (FAP) gene (46, 48) . In cultures of colon carcinoma HT 29 cells sphingosine induced apoptosis and inhibited proliferation by decreasing the level of free β-catenin (48) .
Purified intestinal Alk-SMase (34) from the brush border of the gut, inhibited proliferation of colon carcinoma HT29 cells (18) . Dietary sphingolipids may also interact with bile acids to counteract their cocarcinogenic action in colon (30) and with sterols to cause inhibition of cholesterol absorption and delayed sphingomyelin (Sm) digestion (37) . To understand the sequence of events involved in the mediation of these effects knowledge about the participating enzymes is crucial.
Whereas Alk-SMase was recently purified and cloned (5, 9, 10) , the intestinal ceramidases have not been purified and fully characterized in the purified form. Early studies demonstrated the presence of ceramidase with neutral pH optimum in the mucosa, in brush border preparations, and in intestinal content (35) . Later purified bile salt stimulated lipase (BSSL) in pancreas and human milk was shown to have lipoamidase (19) and ceramidase activity (38) . Most of the intestinal neutral ceramidase activity can, however, not be attributed to BSSL. The longitudinal distribution of ceramidase activity in the rat intestine was different (25) , and neutral ceramidase of rat and human intestinal content was separated from and differed in properties from BSSL (11) . Furthermore mucosal neutral ceramidase activity was present in BSSL (-/-) mice (20) . In this study we further examined the identity of the enzyme accounting for the major digestive ceramidase activity in the gut.
The first possibility was that it is a member of the highly conserved neutral/alkaline ceramidase family. Members of this family have been purified and/or cloned from a number of tissues as kidney (29) , rat brain (13), mouse liver (40, 50) , human liver (14) and endothelial cells (44) , and from bacteria (41), yeast (26, 27) and Drosophila (53) . During the progress of this work Choi et al cloned mouse neutral ceramidase and reported a high expression of neutral ceramidase in mouse intestine and kidney (6) . The second possibility was that the intestinal ceramidase activity is accounted for by a brush border enzyme related to another enzyme families e.g. peptidases or lipases. This possibility was not considered unlikely since we recently found that Alk-SMase is not homologous to any other known sphingomyelinase but a new tissue specific ectoenzyme related to the alkaline nucleotidase/phosphodiesterase (NPP) family (9) . We now purify neutral ceramidase from a luminal bile salt eluate of rat small intestine and find that the enzyme is identical or closely related to the neutral ceramidase 2 from rat kidney (29) and highly homologous to the mouse neutral ceramidase recently shown to be expressed also in the intestine (6) . Characterization of the purified enzyme indicates important physiological roles of the enzyme in ceramide digestion.
Material and Methods

Materials.
14 C-octanoic acid was purchased from American Radiolabeled Chemicals Inc. followed by reacting the anhydride with D-erythro-sphingosine. The labeled ceramide was purified with flash column chromatography, and the purified ceramide had a specific activity of 15.7 mCi/mmol with radiochemical purity of more than 97% (38) . Synthesis of D-erythro- counting. The total dpm in the upper phase was calculated. The distribution of released fatty acids in the upper phase under these condition was 90 %, which was considered in calculation of enzyme activity (25) . After the detergent effects on the activity of the purified enzyme had been considered the assay condition was changed to 50 mM Tris-HCl buffer pH 8.0 with 8 mM CHAPS, due to the lower cost of CHAPS than of TC.
Purification of ceramidase
Collection of intestinal protein: Thirty rats fasted overnight were anesthetized i.m. with for 30 min at 37 ˚C. After the preincubation the ceramidase activity was measured. The activity of trypsin was verified using benzoyl-DL-arginine-p-nitroanilide as substrate (17) .
Mass spectroscopic analysis:
The purified enzyme band from the SDS polyacrylamide gel electrophoresis was eluted and subjected to trypsin digestion. The fragments were then subjected to MALDI-TOF analysis. These analyses were performed by methods established at the Swegene Proteomics Unit, Lund, Sweden. Briefly the gel was stained by GelCode Blue and the ceramidase band cut and subjected to a procedure involving destaining and dehydration/rehydration, reduction/alkylation, trypsin digestion and extraction of peptides.
Results
Purification of ceramidase
The results from the different chromatographic steps are summarised in Table 1 . The protein peak that was not retained on the HQ column contained Alk-SMase and was collected and used for purification of this enzyme (5). The ceramidase was retained on the column and the enzyme was eluted with 0.5 M NaCl. The fractions with ceramidase activity were pooled and desalted on PD-10 columns. On the subsequent Hi Trap Q XL column the ceramidase was retained to the column and was eluted with a NaCl gradient as a broad peak between 0.02 M-0.3 M NaCl, with maximal ceramidase activity at 0.1 M NaCl (Figure 1a ). During elution thereafter with equilibration buffer containing 0.5 % (w/v) Triton X-100 a second ceramidase peak was detected, which was not further investigated in this paper. The ion exchange step gave a 13-fold increase of the specific activity with a recovery of 20 % (Table 1 ).
In the subsequent HIC step the pooled fractions with ceramidase activity were applied to a Hi Trap Butyl FF column. Ceramidase was retained when applied in 1 M ammonium sulphate.
When the salt concentration was reduced gradually a distinct peak containing ceramidase activity was eluted between 0.38 M -0 M ammonium sulphate. The maximum ceramidase activity was detected at 0.15 M ammonium sulphate (Figure 1b ). This purification step yields 244 fold purification. The recovery was 12 % of the ceramidase activity obtained from the initial HQ chromatography (Table I ).
In the last step an aliquot of 200 µl of the concentrated ceramidase peak from the preceding step was applied to a Superdex 200 HR 10/13 column with a total volume of 25 ml.
Ceramidase was eluted as a distinct peak at an elution volume of 13.5 ml (Figure 1c ). After this step 5 % of the original ceramidase activity remained and the increase in specific activity was 307-fold, compared to the ceramidase containing protein fraction from the initial HQ column (Table 1) .
In initial experiments most of the enzyme activity in hydrophobic interaction and gel filtration steps was lost when no detergent was present. Addition of 0.005 % Triton X-100 was found to be sufficient to avoid this problem and did not interfere with the ceramidase assay. This detergent concentration also gave a favourable elution pattern.
The protein composition of the ceramidase containing peaks was monitored by SDS-page (Fig 2a) . After incubation the native enzyme with glycoprotein deglycosylation kit a major protein band with a mass of about 97 kDa was observed (Figure 2b ).
Characterization of ceramidase
Mass spectroscopic analysis
The MALDI-TOF analysis identified 12 peptide fragments with sequences identical to parts of the sequence for the ceramidase purified from rat kidney by Mitsutake et al (29) . 
Effects of pH, ions and bile salts
Effects of pH: Intestinal ceramidase has a broad pH optimum. The enzyme has optimal activity between pH at 6 and 8 and is active at a pH as high as 9.5. At pH lower than 5.0 the ceramidase has little activity ( Figure 4) .
Effects of cations:
The ceramidase activity of the pure enzyme was strongly inhibited by Zn
2+
.
As low concentration as 0.2 mM Zn 2+ caused a more than 90 % inhibition. Also Cu 2+ was distinctly inhibitory, causing a more than 80 % inhibition at 2 mM or higher concentrations.
Li + ions had a slight inhibitory effect whereas Mn
, Mg 2+ and Ca 2+ had no effect on the ceramidase activity ( Figure 5 ). mM concentration, and GDC and TDC were stimulatory only at 1 mM or lower concentrations. All bile salts were inhibitory at high concentrations (figure 6a). The effects of CHAPS on ceramidase activity were similar to that of TC and GC (figure 6b). CHAPS was as effective as TC an GC and had maximal stimulatory effect at 8 mM concentration. Higher concentration of CHAPS tended to inhibit the enzyme. Triton X-100 had an inhibitory effect on ceramidase even at low concentration (Figure 6c ). The presence of 0.005% Triton X-100 in the chromatographic steps did, however, not interfere with the monitoring of the purification with the aliquot sizes used.
Activity against octanoyl-sphingosine and palmitoyl-sphingosine
Two substrates were examined. 14 C-octanoyl-sphingosine was used for the assay during the purification and characterization of the enzyme. The reason is that this substrate has higher micellar solubility in presence of bile salt and provides a sensitive and reliable assay. 
Effects of proteolytic enzymes
Since trypsin and chymotrypsin are present in the intestine and ceramidase is exposed to these enzymes at the brush border and in the lumen, we examined whether ceramidase is rapidly inactivated by or resistant to these proteases. The ceramidase was preincubated with various concentrations of trypsin and chymotrypsin followed by measuring ceramidase activity.
Trypsin and chymotrypsin in concentrations up to 1 mg per ml had no effect on ceramidase activity during preincubation at 37 o C for 30 minutes, indicating that the enzyme in its native form is resistant to the major pancreatic proteases. Trypsin efficiently hydrolysed benzoyl-
DL-p-nitroanilide under the conditions used (data not shown).
Discussion
This paper reports the first purification and characterization of rat intestinal neutral ceramidase. The enzyme can be released from the mucosa by bile salts at a concentration that is not tissue damaging. Together with earlier data showing that the enzyme is present in rat (25) and human (11) intestinal content and enriched in brush border preparations (35) this indicates that it is a releasable ectoenzyme from the brush border. The luminal bile salt eluate provided a favourable starting material that is enriched in the enzyme. A similar procedure was used in our earlier purification procedure for Alk-SMase, which is also located at the brush border surface and released into the lumen (10) . By a series of chromatographic steps a protein appearing as a single protein band at SDS-page with a molecular mass corresponding to 116 kDa was obtained. A crucial step was the hydrophobic interaction chromatography in the presence of a low concentration of detergent (0.005 % Triton X-100) that gave effective purification.
The MALDI-TOF analysis identified the purified enzyme as a member of the neutral/alkaline ceramidase family. Twelve fragments containing 8-18 amino acids each and a total of 160 amino acids are identical to sequences in the segment containing amino acid 107-251 and 617-736 in the neutral ceramidase 2 earlier purified and cloned from rat kidney and shown to be located in the apical membrane of the renal tubular cells (Figure 3a ) (29) . The sequence of rat kidney neutral ceramidase 2 also exhibits 92% homology with the mouse neutral/alkaline ceramidase 2 ( Figure 3b ) which is expressed at mRNA level in several tissues including the small intestine (Mn 104900, dbEST library ID 7218, Riken full-length cDNA).
Thus the intestinal ceramidase purified in this study is very likely a product of the neutral ceramidase 2 gene. We have not excluded that it is an isoform that may be differently spliced than the kidney enzyme. Nor have we excluded that other neutral ceramidases may be expressed in the intestine. During the progress of the work Choi et al (6) reported that the highly homologous (92%) mouse neutral ceramidase 2 is strongly expressed in both duodenum, jejunum and ileum, with highest levels in the jejunum. This is in agreement with our studies of the longitudinal distribution of neutral ceramidase in the rat intestine (25) .
The enzymatic properties of the enzyme purified in the present study are also identical to those of the neutral ceramidase from kidney (29) . The molecular mass, the broad pH optimum between 6 and 8, and the effects of metal ions are all similar. degree of glycosylation and it has been suggested that mannose glycosylation is essential for its association as a type II transmembrane protein with the tubular membrane in the kidney (49) . The change in molecular mass observed after deglycosylation in our study (Fig 2b) indicates a high degree of glycosylation also of the intestinal ceramidase.
The longitudinal distribution and the resistance to pancreatic proteases make the enzyme suited for a key role in the digestion of ceramide. In our earlier studies neutral ceramidase was found throughout the small intestine (25) . In BSSL gene knockout mice the total ceramidase was decreased only in the most proximal part where BSSL is normally abundant, but not in the remaining small intestine (20) . The enzyme is thus expected to be most active in the part of the small intestine where most of the lipid digestion has been finished but where the bile salt concentration is still high. In the present study the activity of the enzyme was found to be influenced by bile salts. The trihydroxy bile salts TC and GC stimulated over a relatively broad range and may have a stimulatory effect in vivo. The dihydroxy bile salts, which have a lower critical micellar concentration also, had their optimal effect at lower concentration and were strongly inhibitory at higher concentrations. To evaluate the role of bile salts for the kinetics of ceramide hydrolysis in vivo is therefore difficult on the basis of the present data. Ceramidase generates free sphingosine which is absorbed much more efficiently than long chain ceramides (34) . Due to the high levels of sphingosine-1-phosphokinase in the mucosa (16) the sphingosine is also rapidly converted to S-1-P that could act as a signal to favour cell growth and survival in the mucosa. Sphingosine may also be rapidly reacylated to ceramide in the mucosal cell. Hypotheses regarding the biological significance of the intestinal ceramidase must therefore consider both the elimination of ceramide, the rapid absorption and metabolism of the sphingosine formed and the further conversion of S-1-P to palmitaldehyde and ethanolamine by S-1-P lyase (32) , an enzyme that is found in higher levels in the gut than in any other tissue (51) .
Due to the significant content of Sm in milk the significance of sphingolipid metabolism in the gut may be particular important in the suckling newborn. Interestingly both the rat lactase-phlorizine hydrolase that catalyses ceramide formation from glycosphingolipids (21, 43) intestinal neutral ceramidase in the mouse (6) and the Alk-SMase in the rat (24) are promptly expressed during late gestation soon before delivery. All three enzymes are thus developmentally regulated and appear with the differentiated absorptive epithelium just in time to participate in digestion of milk sphingolipids. Recent studies on newborn rats receiving artificial milk containing Sm or equivalent amounts of phosphatidylcholine suggested that Sm may influence maturation of the small intestine as judged by differences in lactase levels and morphological criteria (31) . The relation of the gut ceramidase to neonatal nutrition and biological effects of suckling is an thus interesting area for further study.
In summary the neutral ceramidases found in the gut brush border, the apical membrane of the renal tubular cells (29) and in the caveolae of endothelial cells (44, 45) ceramidase-containing fractions were identified by using a ceramidase assay with 14 Coctanoyl-sphingosine as substrate as described in method section. Activity is expressed as dpm in upper phase containing hydrolysis products. Values are mean ± SD of three observations and hydrolysis rates expressed as % dpm in upper phase of total dpm added. 
